Summary
Introduction
The effect of enhanced diuresis on the activity of the renal kalliirein-kinin system has been studied in different experimental models. Acute diuretic responses have been provoked by acute waterloading [l, 21, by intragastric or intravenous administration of isotonic saline solution [3-51 or by the administration of various diuretics such as frusemide [6, 71, acetazolamide [61, bumetanide or Bendroflumethiazide 181. In all these investigations, diuresis was accompanied by an elevated excretion of renal kallikrein. Conversely, potassium-sparing diuretics, such as spironolactone [9], reduced the activity of renal kallikrein. Since the influence of an acute osmotic diuresis on the renal kallikrein-kinin system has not been reported so far, we studied the effects of repeated injections of mannitol on urinary and renal kallikrein activity.
Materials and methods
Twelve male Sprague-Dawley rats weighing 223.3 5 2.6 g were kept in individual cages and fed with a standard rat chow (100 mmol of Na/kg and 200 mmol of K/kg; Sniff). After 3 days the rats were divided into two groups of six rats each. All animals were anaesthetized with pentobarbital sodium (Nembutal; 30 mg/kg intraperitoneally). A catheter (PP 50) was placed in the femoral vein for the injection of mannitol or NaCl solution (0-9 g/l:saline) respectively. Urine was collected through a catheter placed in the bladder; to avoid urine losses the urethra was ligated.
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Fifteen minutes after surgery urine collection was started. After three control periods of 10 min each, 0-1 ml of a 30% mannitol solution (w/v in saline) was injected intravenously in the six rats of group one (M). Injections of mannitol were repeated after 15 min (0.1 ml) and after 30 rnin (0.05 ml) respectively. This method of mannitol injection was chosen to obtain an increasing and prolonged diuresis rather than a single diuretic peak. The control group (C) received an equal volume of saline at the same time intervals. Urine was collected for 5 rnin immediately after the first and second injection of mannitol; all other collection periods lasted 10 min.
Urinary kallikrein activity was measured by means of a bradykinii radioimmunoassay as described previously [lo, 111. Urine was incubated for 20 min at 37OC and pH 8.5 with an excess of partially purified dog kininogen dissolved in Tris/HCl buffer (0-1 mol/l); 1,lOo-phenanthroline and disodium EDTA were added as kininase inhibitors. The reaction was stopped by the addition of 96% (v/v) ethanol, which also precipitated the remaining kininogen. After centrifugation and evaporation of the alcohol, the kinins released during the period of incubation were measured by a bradykinin radioimmunoassay. The kallikrein activity was expressed as pg of bradykinin min-' incubation ml-I of urine. Kallikrein excretion was calculated on the basis of urine volume per minute. UKAL, kallikrein activity; kallikrein excretion = kallikrein activity x UV min-'). The intra-assay variation of this assay was 5.5 & 1.5%, the inter-
To measure kallikrein activity in the renal cortex the left kidney was removed at the end of the experiment. The renal cortex was carefully separated from the medulla, weighed and immediately homogenized. For homogenization Tris buffer (0.2 mol/l, pH 8.2) was added in a ninefold volume of the cortex weight. Subsequently, to 2 ml of homogenate 3 ml of 0.8% deoxycholic acid dissolved in water was added to give a final concentration of 0.5% in the homogenate. The! now 1:25 diluted (w/v) homogenate was centrifuged for 30 min at 50000g and 4°C and kallikrein activity was measured in thC supernatant by an amidolytic assay with the chromogenic substrate H-D-ValLeu-Arg-p-nitroanilide (Kabi). To 0.4 ml of the diluted supernatant 0.5 ml of Tris buffer (0.2 mol/l) and 0 -1 ml of substrate solution (1.5 mmol/l) were added; the mixture was incubated at 37OC for 30 min. The reaction was stopped by the addition of 250 kallikrein inhibiting units (KIU) of aprotinin (Trasylol, Bayer) in 0.1 ml of buffer solution. To exclude a non-specific splitting of the substrate, a control was made for each sample by addition of aprotinin (500 KIU/ml of buffer) to the incubation medium. A,,, of the cleaved chromophore p-nitroaniline was measured photometrically (spectrophotometer 550 A, Perkin-Elmer). Kallikrein activity was calculated as described by Amundsen, Putter, Friberger, Knos, Larsbraten & Claeson [ 121 and expressed as m-units/g of tissue. Since the tripeptide substrate has a much lower sensitivity for plasma kallikrein than for glandular kallikreins [ 131, no difference in kallikrein activity was observed between tissue samples (1 : 100 diluted) taken from perfused (saline) and those from non-perfused kidneys. The values of kallikrein activity determined by this assay correlated highly with the values obtained by the aforementioned bradykinin radioimmunoassay (r = 0.9698, n = 37, P < 0.001). Hence, the activity of kallikrein can be determined in kidneys from which blood has not been removed completely, as performed in this experiment.
To measure aldosterone, blood was collected at the end of the experiment after rats were decapitated and calcium heparin (Calciparin, Nattermann) was added. After centrifugation, aldosterone was determined in the plasma by radioimmunoassay as previously described [ 141. Sodium and potassium in the urine were measured by means of a flame photometer with an internal standard (Klina, Beckman). Total protein in the renal cortex was determined by the method of Lowry, Rosebrough, Farr & Randall [151 with bovine serum albumin as a standard.
SEM. The statistical significance of differences between means was calculated by Student's t-test. Significance of correlations was tested against zero.
Results
The first injection of mannitol caused a significant increase in both urine volume and urinary kallikrein excretion (Table l) , kallikrein activity remaining unchanged during the first 5 min; afterwards, it decreased continuously (Fig. 1) . The second injection of mannitol was followed by a more marked diiiresis, but the increase in kallikrein excretion was less pronounced than after the first injection. After the third injection a prolonged diuresis was obtained, but urinary kallikrein excretion decreased gradually and, towards the end of the experiment. it was significantly lower than in the control rats (Table  1) . Kallikrein activity in urine was still diminished when urine volume had almost returned to control values (Fig. 1) . After both the first and the second mannitol injection sodium and potassium excretion rose for a short period only and, at the end of the experiment, the electrolyte excretion of rats injected with mannitol did not differ from that of the controls (Nat: Kallikrein activity in the renal cortex calculated per gram of tissue was at the end of the experiment significantly lower in the rats injected with mannitol (Fig. 2) than in the control rats injected with saline. Since the protein content of the cortical tissue was unchanged, the specific kallikrein activity calculated per milligram of the tubular system is washed out by the enhanced urine flow. The course of excretion does not suggest that the production or secretion of kalliirein is stimulated by this type of diuresis. On the contrary, since the activity of kallikrein in renal cortical tissue is diminished at the end of the diuresis period, it may be presumed that the stores of the enzyme within the kidney have been depleted. Possibly the 'wash-out' is a physiological and not a biochemical phenomenon induced by mannitol, since similar findings have been obtained after the administration of frusemide or bumetanide, which also cause only a transient increase in kallikrein excretion, with a subsequent reduction of kallikrein activity in the urine (G.
All values are given as means
onner, Th. Unger, G. Speck, D. Ganten F. Gross, unpublished work) and From these findings it is obvious that the effect of diuresis on the renal kallikrein-kinin system can only be assessed if it is followed up over a sufficiently long period. An initial elevation of kallikrein excretion in urine does not permit conclusions as to what may happen within the kidney, since it may simply be an accompanying effect elicited by a sudden enhancement of urine flow. Probably, the biphasic course of kallikrein excretion occurs in all types of diuresis and the intensity of the initial increase depends on the degree to which urine flow is augmented and on the amount of kallikrein present in the renal tubular system.
Since, in our experiments, the duration of the diuresis was short and of moderate degree, no major changes in the intravascular volume occurred at the end of the experiment. Although plasma concentration of aldosterone rose only slightly, this tendency contrasts in some respect with the decrease in the activity of the renal kallikrein-kinin system, which is usually stimulated by mineralocorticoids [9, 17-201. Such a dissociation between plasma aldosterone concentration and the activity of the renal kallikrein-kinin system has also been described in rats with renal hypertension [211. However, the acute changes we observed cannot be compared with chronic influences on the activity of the renal kallikrein-kinin system both in the urine and in the renal cortex. The short-lasting effects caused by an acute diuresis in anaesthetized rats do not permit any conclusion as to what may happen during prolonged studies in conscious rats. It may, however, be stated that acute diuretic responses, independent of the mechanism by which they are induced, do not stimulate the renal kallikrein-kinin system, but cause only a transient 'passive' increase in kallikrein excretion, with a subsequent depletion of the enzyme measured in the renal cortex.
